http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100523525-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65 |
filingDate | 2002-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2005-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2005-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100523525-B1 |
titleOfInvention | Hybrid Materials For Stabilization And Delivery Of Drugs And Processes For Preparing The Same |
abstract | The present invention provides a drug delivery system having excellent stability, sustained release, and low side effects, and is a hybrid of a layered inorganic material and a drug selected from the group consisting of 3-benzoyl-α-methylbenzeneacetic acid, 4-biphenylacetic acid, and minocycline. To provide.n n n In addition, the present invention provides a method for producing the hybrid material using the coprecipitation method and the ion exchange method according to the properties of the drug. The method may further include coating a surface of the hybrid material.n n n The present invention also provides a pharmaceutical composition comprising the hybrid material. |
priorityDate | 2001-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.